Private Equity
Brainstorm Health Daily: September 6, 2018.: Back in January, a number of leading U.S. health systems announced an ambitious project: They would be banding together to create a non-profit generic drug company in the hopes of combating sky high drug prices and shortages regularly faced by American patients. On Thursday, that initiative got an official name—Civica Rx—in addition to $30 million in funding from a slew of major investors including the Laura and John Arnold Foundation.

In this article